HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $27 Price Target
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsReiterationPrice Target
HC Wainwright & Co. analyst Robert Burns reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $27 price target.
HC Wainwright & Co. analyst Robert Burns reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $27 price target.